东菱精纯克栓酶治疗老年急性脑梗死血液流变学临床观察  

HEMORHEOLOGIEAL INDEXES IN THE ELDERLY ACUTE CEREBRAL INFARCTION TREATED WITH BARTROXOBIN

作　　者：刘雪平[1] 王敏忠[1] 于桂兰[1] 王凤焰[1] 

机构地区：[1]山东省立医院神经科,济南250021

出　　处：《中国血液流变学杂志》2000年第2期116-119,共4页Chinese Journal of Hemorheology

摘　　要：应用东菱精纯克栓酶治疗老年急性脑梗死３８例治疗组，常规治疗 （对照组）３０例。结果：治疗后２１天治疗组显效率明显高于对照组（Ｐ＜０。０１），神经功能缺损评分显著低于治疗前及对照组（Ｐ＜０．００１），全血粘度及纤维蛋白原均较治疗前明显下降。结论：东菱精克栓酶早期治疗老年急性脑梗死疗效肯定，对大面积脑梗死、明显高血压，长期应用抗血小板聚集药物慎重应用。We observed 68 elder patients with acute cerebral infarction,38 of whom treated with Batroxobin.Results: Batroxobin in the patients with acute phase can reduced the neurology disfunction,plasma fibrinogen and whole blood viscosity compared with control group. conclusion: Batroxobin which treated the acute cerbral infarction in the early phase period fo attack is useful. When treating the elder patients with acute cerbral infarction,we should be more carefully in big area infarction, high blood pressure and the use of antiplatelet coagulability drugs for long time.

关 键 词：东菱克栓酶 脑梗塞 老年人 血液流变学 

分 类 号：R743.330.5[医药卫生—神经病学与精神病学] R331.1[医药卫生—临床医学]